These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 23906880)

  • 21. Bartonella entry mechanisms into mammalian host cells.
    Eicher SC; Dehio C
    Cell Microbiol; 2012 Aug; 14(8):1166-73. PubMed ID: 22519749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type IV secretion system of Brucella spp. and its effectors.
    Ke Y; Wang Y; Li W; Chen Z
    Front Cell Infect Microbiol; 2015; 5():72. PubMed ID: 26528442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Trw type IV secretion system of Bartonella mediates host-specific adhesion to erythrocytes.
    Vayssier-Taussat M; Le Rhun D; Deng HK; Biville F; Cescau S; Danchin A; Marignac G; Lenaour E; Boulouis HJ; Mavris M; Arnaud L; Yang H; Wang J; Quebatte M; Engel P; Saenz H; Dehio C
    PLoS Pathog; 2010 Jun; 6(6):e1000946. PubMed ID: 20548954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.
    de Figueiredo P; Ficht TA; Rice-Ficht A; Rossetti CA; Adams LG
    Am J Pathol; 2015 Jun; 185(6):1505-17. PubMed ID: 25892682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of Bartonella spp. stealth pathogens: from subclinical infections to vasoproliferative tumor formation.
    Pulliainen AT; Dehio C
    FEMS Microbiol Rev; 2012 May; 36(3):563-99. PubMed ID: 22229763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An optimal set of features for predicting type IV secretion system effector proteins for a subset of species based on a multi-level feature selection approach.
    Esna Ashari Z; Dasgupta N; Brayton KA; Broschat SL
    PLoS One; 2018; 13(5):e0197041. PubMed ID: 29742157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brucella spp. Virulence Factors and Immunity.
    Byndloss MX; Tsolis RM
    Annu Rev Anim Biosci; 2016; 4():111-27. PubMed ID: 26734887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epistatic Interplay between Type IV Secretion Effectors Engages the Small GTPase Rab2 in the
    Smith EP; Cotto-Rosario A; Borghesan E; Held K; Miller CN; Celli J
    mBio; 2020 Mar; 11(2):. PubMed ID: 32234817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pestilence, persistence and pathogenicity: infection strategies of Bartonella.
    Minnick MF; Battisti JM
    Future Microbiol; 2009 Aug; 4(6):743-58. PubMed ID: 19659429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evasion of anti-infectious immunity by Brucella - A review].
    Quan W; Yang Y
    Wei Sheng Wu Xue Bao; 2016 May; 56(5):747-52. PubMed ID: 29727136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on human bartonelloses.
    Pretorius AM; Kelly PJ
    Cent Afr J Med; 2000 Jul; 46(7):194-200. PubMed ID: 11317589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brucellosis and type IV secretion.
    de Jong MF; Tsolis RM
    Future Microbiol; 2012 Jan; 7(1):47-58. PubMed ID: 22191446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brucella evasion of adaptive immunity.
    Martirosyan A; Gorvel JP
    Future Microbiol; 2013 Feb; 8(2):147-54. PubMed ID: 23374122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of the human pathogenic Brucella species with their hosts.
    Atluri VL; Xavier MN; de Jong MF; den Hartigh AB; Tsolis RM
    Annu Rev Microbiol; 2011; 65():523-41. PubMed ID: 21939378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A T4SS Effector Targets Host Cell Alpha-Enolase Contributing to
    Marchesini MI; Morrone Seijo SM; Guaimas FF; Comerci DJ
    Front Cell Infect Microbiol; 2016; 6():153. PubMed ID: 27900285
    [No Abstract]   [Full Text] [Related]  

  • 36. [MOLECULAR ASPECTS OF BRUCELLA PERSISTENCE].
    Kulakov Yu K
    Mol Gen Mikrobiol Virusol; 2016; 34(1):3-8. PubMed ID: 27183714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bartonella spp. as emerging human pathogens.
    Anderson BE; Neuman MA
    Clin Microbiol Rev; 1997 Apr; 10(2):203-19. PubMed ID: 9105751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ecological fitness and strategies of adaptation of Bartonella species to their hosts and vectors.
    Chomel BB; Boulouis HJ; Breitschwerdt EB; Kasten RW; Vayssier-Taussat M; Birtles RJ; Koehler JE; Dehio C
    Vet Res; 2009; 40(2):29. PubMed ID: 19284965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial persistence within erythrocytes: a unique pathogenic strategy of Bartonella spp.
    Seubert A; Schulein R; Dehio C
    Int J Med Microbiol; 2002 Feb; 291(6-7):555-60. PubMed ID: 11890558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bartonella bacilliformis: dangerous pathogen slowly emerging from deep background.
    Ihler GM
    FEMS Microbiol Lett; 1996 Oct; 144(1):1-11. PubMed ID: 8870245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.